Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer Journal Article
| Authors: | Ito, H.; Mo, Q.; Qin, L. X.; Viale, A.; Maithel, S. K.; Maker, A. V.; Shia, J.; Kingham, P.; Allen, P.; DeMatteo, R. P.; Fong, Y.; Jarnagin, W. R.; D'Angelica, M. |
| Article Title: | Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer |
| Abstract: | Purpose: The aim of this study was to build a molecular prognostic model based on gene signatures for patients with completely resected hepatic metastases from colorectal cancer (MCRC). Methods: Using the Illumina HumanHT-12 gene chip, RNA samples from the liver metastases of 96 patients who underwent R0 liver resection were analyzed. Patients were randomly assigned to a training (n = 60) and test (n = 36) set. The genes associated with disease-specific survival (DSS) and liver-recurrence-free survival (LRFS) were identified by Cox-regression and selected to construct a molecular risk score (MRS) using the supervised principle component method on the training set. The MRS was then evaluated in the independent test set. Results: Nineteen and 115 genes were selected to construct the MRS for DSS and LRFS, respectively. Each MRS was validated in the test set; 3-year DSS/LRFS rates were 42/32% and 79/80% for patients with high and low MRS, respectively (p = 0.007 for DSS and p = 0.046 for LRFS). In a multivariate model controlling for a previously validated clinical risk score (CRS), the MRS remained a significant predictor of DSS (p = 0.001) and LRFS (p = 0.03). When CRS and MRS were combined, the patients were discriminated better with 3-year DSS/LRFS rates of 90/89% in the low risk group (both risk scores low) vs 42/26% in the high risk group (both risk scores high), respectively (p = 0.002/0.004 for DSS/LRFS). Conclusion: MRS based on gene expression profiling has high prognostic value and is independent of CRS. This finding provides a potential strategy for better risk-stratification of patients with liver MCRC. © 2013 Ito et al. |
| Journal Title: | PLoS ONE |
| Volume: | 8 |
| Issue: | 12 |
| ISSN: | 1932-6203 |
| Publisher: | Public Library of Science |
| Date Published: | 2013-12-01 |
| Start Page: | e81680 |
| Language: | English |
| DOI: | 10.1371/journal.pone.0081680 |
| PROVIDER: | scopus |
| PMCID: | PMC3858250 |
| PUBMED: | 24339954 |
| DOI/URL: | |
| Notes: | Export Date: 3 March 2014 -- CODEN: POLNC -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work